Insulin Glargine 300 UNT/ML [Toujeo]

DRUG2 trials

Sponsors

prof dr Pieter Gillard, Changhua Christian Hospital

Conditions

Diabetic KetoacidosisHyperglycaemic Crisis in Diabetes MellitusHyperglycaemic Hyperosmolar Nonketotic SyndromeType 1 Diabetes

Phase 2

Concurrent Subcutaneous Basal Insulin and Intravenous Insulin Pump in Hyperglycemic Crisis Patients Under Critical Care

Changhua Christian HospitalDiabetic Ketoacidosis, Hyperglycaemic Crisis in Diabetes Mellitus, Hyperglycaemic Hyperosmolar Nonketotic Syndrome

Start: 2022-03-01End: 2024-01-31Target: 70Updated: 2022-03-10

Unknown Phase

Evaluation of Glycemic Control and Quality of Life in Adults With Type 1 Diabetes During Continuous Glucose Monitoring When Switching to Insulin Glargine 300 U/mL

CompletedNCT05109520

prof dr Pieter GillardType 1 Diabetes

Start: 2021-09-08End: 2021-10-14Updated: 2022-08-30

Related Papers

Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study

Diabetes Technology & Therapeutics2024-02-22